← Back to headlines
FDA Approves Afrezza, Inhaled Insulin for Children and Adolescents with Diabetes
MannKind has announced FDA approval for Afrezza®, the first and only inhaled mealtime insulin specifically for children and adolescents aged 6 and older living with diabetes.
29 May, 16:30 — 29 May, 16:30
Related Stories
Amazon's First Sale Receipt Goes Viral, Drawing Reactions from Bezos and Musk
just now
Philippine Senator Bam Aquino Calls Video Games a 'Convenient Scapegoat' for School Violence
just now
Eli Lilly's Biotech Startup Factory in San Diego
29m ago
Bitcoin Faces Potential 30% Drop as Strategists Eye Critical $60,000 Level
44m ago